Press "Enter" to skip to content

Glenmark gets USFDA nod for generic version of acne treatment gel

Citing IQVIATM sales data, Glenmark said BenzaClin Gel, 1 per cent |5 per cent had sales of USD 99.4 million in the 12-month period ended January 2019.

Original source: https://health.economictimes.indiatimes.com/news/pharma/glenmark-gets-usfda-nod-for-generic-version-of-acne-treatment-gel/68436514?utm_source=RSS&utm_medium=ETRSS

Also Read:   Mylan, Biocon launch biosimilar of cancer drug Herceptin in Australia